Glenmark To Focus On Original Drugs

Indian drugmaker Glenmark Pharmaceuticals is looking to boost growth by spinning off its generics and active pharmaceutical ingredient (API) businesses, concentrating on original R&D and branded formulations. The company has also established a new subsidiary in Romania, boosting its presence in Central and Eastern Europe (CEE). BMI endorses these developments as the former will facilitate strategic investments, while the latter will result in increased

To read the full article, please choose one of the following options: